$1.19
-0.01-0.83%
At close: May 12, 5:00 PM EST
$1.17
-0.0194-1.63%
After Hours: 7:50 PM EST
BioXcel Therapeutics Inc Earnings Estimates
BTAINASDAQ
BioXcel Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BTAI
BioXcel Therapeutics (BTAI) is scheduled to report Q1 earnings on May 26, 2026. Analysts estimate EPS of $-0.51 and quarterly revenue of $363.19K.
In the most recent quarter (Q4), BioXcel Therapeutics reported EPS of $-0.58, missing estimates of $-0.52 by 0.12%. Revenue came in at $256.00K, exceeding the estimate of $142.91K by 0.79%.
BioXcel Therapeutics has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, BioXcel Therapeutics has averaged an EPS surprise of 0.37% and a revenue surprise of 0.57%.
Earnings Date
May 26
EPS Estimate
$-0.510
Quarterly Revenue Estimate
$363.19K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$642.00K
BioXcel Therapeutics Earnings History
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Loading calendar...
BioXcel Therapeutics (BTAI) Earnings Per Share
The chart below shows BioXcel Therapeutics's reported EPS compared to analyst estimates over recent quarters.
BioXcel Therapeutics (BTAI) Revenue
The chart below shows BioXcel Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics (BTAI) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on March 27, 2026 for Q4.
What were the latest earnings per share (EPS) for BioXcel Therapeutics (NASDAQ:BTAI)?
The Actual EPS was $-0.58, which missed the estimate of $-0.52.
What were BioXcel Therapeutics’s (NASDAQ:BTAI) revenues?
The Actual Revenue was $256.00K, which beat the estimate of $142.91K.
